TABLE I.
Clinical and Pathological Information.
| Variable | No. of Patients (%) |
|---|---|
| Gender, n = 22 | |
| Female | 2 (9) |
| Male | 20 (91) |
| T stage, n = 22 | |
| Tx | 6 (27.3) |
| T1 | 10 (45.5) |
| T2 | 5 (22.7) |
| T3 | 1 (4.5) |
| T4 | 0 (0) |
| N stage, n = 22 | |
| N1 | 3 (13.6) |
| N2 | 14 (63.7) |
| N3 | 5 (22.7) |
| Site of origin, n = 22 | |
| Tonsil | 12 (54.5) |
| Base of tongue | 4 (18.2) |
| Occult primary | 6 (27.3) |
| HPV status, n = 21 | |
| Positive | 17 (80.9) |
| Negative | 4 (19.1) |
| p16 status, n = 21 | |
| Positive | 20 (95.2) |
| Negative | 1 (4.8) |
| ECS, n = 22 | |
| Positive | 9 (40.9) |
| Negative | 13 (59.1) |
ECS = extracapsular spread; HPV = human papillomavirus; p16 = p16Ink4A.